Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jorge, Ortiz de Urbina"'
Autor:
Miguel-Angel Gómez, Esteban Otero, Valentín Cuervas-Mons, Enrique Fraga, Juan Rodrigo, Pedro López, José Ignacio Herrero, Emilio Fábrega, Josep Martí, Carlos Jimenez, Laura Lladó, Delia D'Avola, Francisco Suárez, Antonio Ríos, M. Trinidad Serrano, Jorge Ortiz de Urbina
Publikováno v:
Liver Transplantation. 23:498-509
Cardiovascular (CV) diseases are recognized longterm causes of death after liver transplantation (LT). The objective of this multicenter study was to analyze the prevalence and the evolution of CV risk factors and CV morbidity and mortality in 1819 L
Autor:
Arkaitz Perfecto Valero, Mikel Gastaca Mateo, Mikel Prieto Calvo, Jorge Ortiz de Urbina López, Andrés Valdivieso López
Publikováno v:
Cirugía Española (English Edition). 96:658-660
Autor:
Andrés Valdivieso López, Arkaitz Perfecto Valero, Jorge Ortiz de Urbina López, Mikel Prieto Calvo, Mikel Gastaca Mateo
Publikováno v:
Cirugía Española. 96:659-661
Publikováno v:
Medicina Clínica. 141:406-410
Autor:
Christophe Laurent, Yves Patrice Le-Treut, Jorge Ortiz-de-Urbina, François-René Pruvot, Martin Oliverius, Jean Gugenheim, Phillipe Bachelier, Ephrem Salamé, Anaelle David, Vincenzo Scuderi, Jürgen Klempnauer, René Adam, Stefano Di-Sandro, Paulette Bioulac-Sage, Jan Lerut, Jean Yves Mabrut, Francis Navarro, Jeroˆme Dumortier, Eric Vibert, Marco Spada, Roberto Troisi, Michele Colledan, Ignacio Gonzalez-Pinto, Laurence Chiche, V. Vincenzo Mazzafero, Bertrand Suc
Publikováno v:
Liver Transplantation
Liver Transplantation, Wiley, 2016, 22 (4), pp.516-526. ⟨10.1002/lt.24417⟩
Liver Transplantation, Wiley, 2016, 22 (4), pp.516-526. ⟨10.1002/lt.24417⟩
International audience; The aim of this study was to collect data from patients who underwent liver transplantation (LT) for adenomatosis; to analyze the symptoms, the characteristics of the disease, and the recipient outcomes; and to better define t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2561f7c6f8b3e2cb218bfe6aed6dd424
https://hal.archives-ouvertes.fr/hal-01873699
https://hal.archives-ouvertes.fr/hal-01873699
Autor:
M. Testillano, A. Ventoso, Patricia Salvador, Patricia Ruiz, Mikel Prieto, Jorge Ortiz de Urbina, J. Bustamante, Andrés Valdivieso, Miguel Montejo, José Rodríguez Fernández, M.J. Suarez, Mikel Gastaca, I. Palomares
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 22(10)
The once-daily prolonged-release formulation of tacrolimus has been recently related with significant graft and patient mid-term survival advantages; however, practical information on the de novo administration after liver transplantation and longter
Autor:
Nerea Leal, Andrés Valdivieso, Itziar Oteo, Mikel Gastaca, Jorge Ortiz de Urbina, Elena Suarez, Rosario Calvo, John C. Lukas
Publikováno v:
European Journal of Clinical Pharmacology. 69:65-74
To define and validate a pharmacokinetic (PK) model for tacrolimus (TAC) that includes patient pathophysiology and has clinical applicability in the first 2 weeks post-liver transplantation (PLT). Routine monitoring records [dose, trough levels (Cmin
Autor:
J. Gonzalez, Jorge Ortiz de Urbina, Mikel Gastaca, A. Ventoso, Patricia Ruiz, Andrés Valdivieso
Publikováno v:
Clinical Transplantation. 25:E320-E326
Hepatic venous outflow obstruction (HVOO) is a rare complication after orthotopic liver transplantation (OLT) usually related to technical issues or to malposition or kinking of the hepatic graft. When HVOO is diagnosed during the early post-transpla
Autor:
Mikel Gastaca, Itziar Oteo, John C. Lukas, Andrés Valdivieso, Jorge Ortiz de Urbina, Rosario Calvo, Elena Suarez, Nerea Leal
Publikováno v:
European Journal of Clinical Pharmacology. 67:671-679
To explore the main factors that make it difficult to empirically monitor tacrolimus (TAC) in the early period post-liver transplantation (LTx), with a specific focus on those aspects related to patient idiosyncrasy and clinical status as well as to
Autor:
Angel Bernardos, Ignacio Gonzalez-Pinto, Jorge Ortiz de Urbina, Santiago Otero, Alejandra Otero, Antoni Rimola, Rafael Martín-Vivaldi, Evaristo Varo, Valentín Cuervas-Mons, José Ignacio Herrero, Jorge Maldonado, Rosa Domínguez-Granados, Elena Barrao
Publikováno v:
Liver Transplantation. 15:1542-1552
This open-label, randomized study compared the efficacy of a regimen of corticosteroids and tacrolimus (standard therapy group, n = 79) with a regimen of daclizumab induction therapy in combination with mycophenolate mofetil and tacrolimus (modified